Deep TMS utilizes specialized H-coils designed to reach deeper brain structures involved in motor control, such as the motor cortex and prefrontal cortex, which are implicated in movement disorders like Parkinson's disease.

Research suggests that Deep TMS may offer moderate improvement in motor symptoms of Parkinson's disease, including bradykinesia (slowness of movement), rigidity, and potentially tremors. Studies have explored bilateral stimulation of the motor and prefrontal cortices.

Unlike Deep Brain Stimulation (DBS), Deep TMS is a non-surgical outpatient procedure that does not require hospitalization or anesthesia. It is generally well-tolerated with minimal systemic side effects. The most common side effects are mild and temporary, such as headache or scalp discomfort.

Deep TMS is being explored as an adjunctive therapy to complement existing pharmacological treatments for movement disorders, potentially enhancing their effectiveness or allowing for lower medication dosages over time.

Emerging research indicates that Deep TMS targeting specific brain regions may also have a positive impact on non-motor symptoms associated with movement disorders, such as depression, anxiety, and cognitive function.